白云山(00874)：天心制药收到国家药监局核准签发的《药品补充申请批准通知书》

Core Viewpoint - Baiyunshan (00874) announced that its subsidiary, Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd., received approval from the National Medical Products Administration for its supplementary drug application, enhancing the market competitiveness of its products [1] Group 1: Product Approval - Tianxin Pharmaceutical's injectable Cefoperazone Sodium and Sulbactam Sodium (1.0g, 1.5g, 2.0g) and Clindamycin Phosphate Injection (2ml: 0.3g, 4ml: 0.6g) have passed the consistency evaluation for generic drug quality and efficacy [1] - The approval is expected to improve the market competitiveness of the aforementioned products [1]